Treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures; treatment of severe osteoporosis in men at increased risk of fracture due to age/bone mineral density (BMD) score
Adults: 2 g/day dissolved in water, prior to bedtime, 2 hours after eating (preferably)
Dosage adjustment in renal impairment: CrCl <30 mL/minute: Not recommended
Product available in various countries; not currently available in the US
Granules, oral suspension: 2 g/sachet (7s, 14s, 28s, 56s, 84s, 100s) [contains phenylalanine]
Do you want to add Medilib to your home screen?